South Africa has received its first batch of the long-acting HIV prevention injection Lenacapavir, with 37 920 doses now in the country. The Department of Health confirmed the development this week, signalling a shift in how HIV prevention could be delivered, particularly in high-burden provinces like Gauteng. The rollout matters now as health officials look to improve adherence and reduce new infections using alternatives to daily medication.